Integrated Analysis of Gut Microbiome Remodeling and Circulating Molecular Biomarker Dynamics Following Long-Term Gluten-Free Diet Adherence in Adult Patients with Celiac Disease

Abstract

Background: Celiac disease is a chronic immune-mediated enteropathy triggered by dietary gluten exposure in genetically susceptible individuals. Although a gluten-free diet remains the cornerstone of treatment, growing evidence suggests that microbiome alterations and persistent molecular abnormalities may continue even after long-term dietary adherence. Understanding the interaction between intestinal microbial communities and circulating molecular biomarkers may provide deeper insights into disease recovery, mucosal healing, and long-term metabolic adaptation. Objective: This study aimed to perform an integrated evaluation of gut microbiome remodeling and circulating molecular biomarker dynamics in adult patients with celiac disease following long-term adherence to a gluten-free diet. Particular attention was directed toward microbial diversity, taxonomic composition, inflammatory mediators, intestinal barrier biomarkers, and metabolic response indicators. Methods: A comparative longitudinal analytical framework was designed based on published clinical datasets involving adult celiac disease patients before and after long-term gluten-free dietary intervention. Gut microbial composition was assessed using high-throughput sequencing approaches, while circulating molecular biomarkers included inflammatory cytokines, intestinal permeability indicators, immune-response mediators, and selected metabolic markers. Multidimensional integration techniques were used to evaluate associations between microbial restructuring and biomarker fluctuations. Results: Long-term gluten-free diet adherence was associated with substantial remodeling of the gut microbiome. Beneficial bacterial taxa demonstrated progressive recovery, whereas several dysbiosis-associated microbial signatures decreased over time. Concurrently, circulating inflammatory biomarkers showed significant reductions, accompanied by improvements in intestinal barrier integrity indicators. Integrated analyses revealed strong associations between microbiome normalization and favorable molecular biomarker profiles. However, complete restoration of microbial composition comparable to healthy controls was not consistently observed, suggesting persistent microbiological footprints of disease despite clinical remission. Conclusion: Long-term gluten-free dietary treatment promotes significant but incomplete restoration of gut microbial ecology and molecular biomarker homeostasis in adult celiac disease. The findings support the concept that microbiome-based monitoring combined with circulating biomarker assessment may enhance disease surveillance, therapeutic evaluation, and precision nutritional management. Future studies integrating microbiomics, metabolomics, and systems biology approaches may further improve personalized care strategies for patients with celiac disease.